Haemophilia
Conditions
Keywords
Haemophilia, Ankle, Arthropathy, Pain, Range of motion, Myofascial techniques
Brief summary
Randomized clinical trial to assess the efficacy of a treatment protocol applied fascial therapy in patients with hemophilic arthropathy ankle, oriented to know and describe the observed differences on the dependent variables: range of motion, pain and physical condition. At the same time, the study will determine whether there are adverse effects or bleeding complications as a result of applied physiotherapy treatment.
Interventions
Physiotherapy by techniques myofascial therapy, in patients with ankle hemophilic arthropathy
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients diagnosed with hemophilia A and B * Adults patients * Patients with hemophilic arthropathy of ankle diagnosed * Patients in prophylactic treatment regimen or on demand treatment with concentrates of FVIII/FIX.
Exclusion criteria
* Patients without ambulation * Patients diagnosed with other congenital coagulopathy (eg, Von Willebrand disease) * Patients who have developed antibodies to FVIII / FIX (inhibitors) * Patients with neurological or cognitive impairments that prevent understanding of questionnaires and test physical * Patients that have not signed the informed consent document.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline bleeding frequency after treatment and at 5 months | Screening visit, within the first seven days after treatment and after five months follow-up visit | Evaluation of the frequency of muscle and joint bleeds through registration. The frequency of bleeding of the ankle joint is measured with a registry given to patients at the beginning of the study. |
| Change from baseline joint pain of ankle after treatment and at 5 months | Screening visit, within the first seven days after treatment and after five months follow-up visit | Change from joint pain of ankle during treatment and follow-up period at 5 months. The perception of ankle pain will be measured using visual analog scale (scale 0-10). |
| Change from baseline joint function after treatment and at 5 months | Screening visit, within the first seven days after treatment and after five months follow-up visit | Change from joint health during treatment and follow-up period at 5 months. Measurement instrument: Haemophilia Joint Health Score (scale 0-20). |
| Change from baseline range of motion after treatment and at 5 months | Screening visit, within the first seven days after treatment and after five months follow-up visit | Change from range of movement of ankle and knee during treatment and follow-up period at 5 months. The range of motion of the ankle joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol. Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Height | Screening visit | Height of patients |
| Age | Screening visit | Age of patients |
| Weight | Screening visit | Weight of patients included in the study |